Your browser doesn't support javascript.
loading
Reproducibility of a prediabetes classification in a contemporary population.
Chadha, Chhavi; Pittas, Anastassios G; Lary, Christine W; Knowler, William C; Chatterjee, Ranee; Phillips, Lawrence S; Aroda, Vanita R; Lewis, Michael R; Pratley, Richard; Staten, Myrlene A; Nelson, Jason; Rasouli, Neda; Brodsky, Irwin.
Afiliação
  • Chadha C; HealthPartners Institute, 8170 33rd Ave S, Bloomington, MN 55425, USA.
  • Pittas AG; Tufts Medical Center, 800 Washington Street, Box #268, Boston, MA, 02111, USA.
  • Lary CW; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, 509 Forest Avenue, Suite 200, Portland, ME, 04101, USA.
  • Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA.
  • Chatterjee R; Duke University, Division of General Internal Medicine, 200 Morris Street, 3rd Floor, Durham, NC, 27701, USA.
  • Phillips LS; Atlanta VA Medical Center, 1670 Clairmont Rd, 151CSC, Decatur, GA, 30033, USA.
  • Aroda VR; Emory University School of Medicine, 201 Dowman Drive, Atlanta, GA, 30322, USA.
  • Lewis MR; MedStar Health Research Institute, 6525 Belcrest Road, #700, Hyattsville, MD, 20782, USA.
  • Pratley R; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, 05405, USA.
  • Staten MA; Advent Health Translational Research Institute for Metabolism and Diabetes, 301 East Princeton Street, Orlando, FL, 32804, USA.
  • Nelson J; National Institute of Diabetes and Digestive and Kidney Diseases, 6701 Democracy Boulevard, Bethesda, MD, 20892, USA.
  • Rasouli N; Tufts Medical Center, 800 Washington Street, Box #268, Boston, MA, 02111, USA.
  • Brodsky I; University of Colorado, School of Medicine, 13001 E 17th Place, Aurora, CO, 80045, USA.
Metabol Open ; 6: 100031, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32812912
AIMS: To assess whether meeting both fasting plasma glucose (FPG) and HbA1c criteria for prediabetes in people at high risk indicates with near certainty the presence of dysglycemia on repeat testing. METHODS: Observational study using data from Vitamin D and Type 2 Diabetes (D2d) study. HbA1c, FPG were measured at screening visit 1; FPG, HbA1c and 2 h plasma glucose (2hPG) measured at screening visit 2 (a median of 21 days later); participants classified as having normal glucose regulation (all 3 tests in normal range), prediabetes or diabetes (at least 1 of 3 tests in diabetes range). A predictive model was developed to estimate the probability of confirming dysglycemia and for detecting diabetes at screening visit 2 based on values of FPG and HbA1c at screening visit 1. RESULTS: Of 1271 participants who met both FPG and HbA1c criteria for prediabetes at screening visit 1, 98.6% exhibited dysglycemia (defined as prediabetes or diabetes) on repeat testing (84.5% were classified as having prediabetes, 14.1% were reclassified as having diabetes). Of those with diabetes, 62.6% were identified by 2hPG alone. CONCLUSIONS: Combined measurement of FPG and HbA1c is a reliable and reproducible measure to identify presence of dysglycemia among people at high risk. A prediction model is provided to help clinicians decide whether an oral glucose tolerance test will provide value in detecting diabetes based on the 2hPG criterion.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Metabol Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Metabol Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
...